Cannara Biotech Inc. has announced that they have raised an additional $10 million of credit facilities from BMO Commercial Banking via a $5 million increase in their term loan facility and a $5 million increase in their revolving line of credit. Under the terms of the initial agreement that was announced on June 1, 2022 , the credit facility included a three-year term loan for $45 million with an accordion for up to an additional $10 million and a $5 million line of credit. Other favorable terms as part of the original deal included a declining interest rate over time.

Cannara Biotech Inc., a Bristol Investor Relations client, is a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft..

Read the full press release here: Cannara Biotech Inc. Secures An Additional $10 Million In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking